140 related articles for article (PubMed ID: 11461761)
1. Esters of chlorambucil with 2-substituted 1,4-dihydroxy-9,10-anthraquinones as multifunctional anticancer agents.
Jin GZ; You YJ; Kim Y; Nam NH; Ahn BZ
Eur J Med Chem; 2001 Apr; 36(4):361-6. PubMed ID: 11461761
[TBL] [Abstract][Full Text] [Related]
2. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
Jin G; You Y; Ahn B
Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
[TBL] [Abstract][Full Text] [Related]
3. 2-(1-Oxyalkyl)-1,4-dioxy-9,10-anthraquinones: synthesis and evaluation of antitumor activity.
Jin GZ; Song GY; Zheng XG; Kim Y; Sok DE; Ahn BZ
Arch Pharm Res; 1998 Apr; 21(2):198-206. PubMed ID: 9875431
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of the antitumor activity of 2-substituted 1,4-dihydroxy-9,10-anthraquinones.
Tam MN; Nam NH; Jin GZ; Song GY; Ahn BZ
Arch Pharm (Weinheim); 2000 Jun; 333(6):189-94. PubMed ID: 10909191
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.
Antonini I; Polucci P; Cola D; Palmieri G; Martelli S; Bontemps-Gracz M
Farmaco; 1993 Dec; 48(12):1641-8. PubMed ID: 8135988
[TBL] [Abstract][Full Text] [Related]
6. 2- or 6-(1-azidoalkyl)-5,8-dimethoxy-1,4-naphthoquinone: synthesis, evaluation of cytotoxic activity, antitumor activity and inhibitory effect on DNA topoisomerase-I.
Chae GH; Song GY; Kim Y; Cho H; Sok DE; Ahn BZ
Arch Pharm Res; 1999 Oct; 22(5):507-14. PubMed ID: 10549580
[TBL] [Abstract][Full Text] [Related]
7. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
Zagotto G; Supino R; Favini E; Moro S; Palumbo M
Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of antitumor activity of novel 1,4-naphthoquinone derivatives (IV).
Kim BH; Yoo J; Park SH; Jung JK; Cho H; Chung Y
Arch Pharm Res; 2006 Feb; 29(2):123-30. PubMed ID: 16526275
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
Idowu T; Samadder P; Arthur G; Schweizer F
Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
[TBL] [Abstract][Full Text] [Related]
11. Effect of the aryl substituent on antitumor activity of 2-substituted-1,4-dihydroxy-9,10-anthraquinones and 2-substituted-anthracene-1,4,9,10-tetraones.
Nam NH; Jin GZ; Tam MN; Ahn BZ
Arch Pharm Res; 1999 Dec; 22(6):592-607. PubMed ID: 10615866
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.
Giraud I; Rapp M; Maurizis JC; Madelmont JC
J Med Chem; 2002 May; 45(10):2116-9. PubMed ID: 11985479
[TBL] [Abstract][Full Text] [Related]
13. 2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity.
Tam MN; Nam NH; Jin GZ; Ahn BZ
Arch Pharm Res; 2000 Aug; 23(4):283-7. PubMed ID: 10976572
[TBL] [Abstract][Full Text] [Related]
14. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
Bielawska A; Bielawski K; Wołczyński S; Anchim T
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
[TBL] [Abstract][Full Text] [Related]
19. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
Zee-Cheng RK; Cheng CC
J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
